ResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Credits
February 01, 2023 08:30 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
President and Co-Founder of the Schultes Center for Amazonian Ethnobotanical Research Joins Luminous Mind Inc. Scientific Advisor Network
March 10, 2022 13:00 ET
|
Luminous Mind Inc.
BOSTON, March 10, 2022 (GLOBE NEWSWIRE) -- Luminous Mind Inc. today announced the appointment of ethnobotanist, Michael J. Maki to its Scientific Advisory Network to assist in searching for...
Former Nature Genetics Chief Editor Joins the Research Team at Luminous Mind Inc. to Find Treatments for Psychiatric Illnesses
March 03, 2022 09:00 ET
|
Luminous Mind Inc.
BOSTON, March 03, 2022 (GLOBE NEWSWIRE) -- Luminous Mind Inc. announced the appointment of geneticist Myles Axton, Ph.D., to its Research Team. Founded in 2021, Luminous Mind Inc. has reassembled an...
Praxis Precision Medicines to Present at Citi’s 16th Annual BioPharma Virtual Conference
September 01, 2021 09:00 ET
|
Praxis Precision Medicines, Inc.
CAMBRIDGE, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
New Patent on Software Games for Depression
August 29, 2018 08:00 ET
|
Posit Science
SAN FRANCISCO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Posit Science, maker of BrainHQ online brain exercises and assessments, announced that it has been awarded a new patent by the US Patent Office — US...